Guard and colleagues32
|
1998 |
Canada |
50 |
2–8 yr |
Penile, hernia/hydrocele, orchidopexy, hypospadias and hernia |
NR |
2.5% |
5–10 mg kg−1 h−1
|
NR |
Rüsch and colleagues33
|
1999 |
Germany |
105 |
3–8 yr |
Strabismus repair |
NR |
1%–1.5% |
10 mg kg−1 h−1
|
NR |
Lovstad and Stoen34
|
2001 |
Norway |
42 |
NR |
Osteotomy |
NR |
NR |
4–10 mg kg−1 h−1
|
5-point categorical VRS |
Schmidt and colleagues35
|
2001 |
Germany |
120 |
6 months to 16 yr |
Lower abdominal surgery |
1 or 2 |
2.4%–3.3% |
7.5 mg kg−1 h−1
|
Modified Objective Pain Discomfort Scale |
Cohen and colleagues36
|
2003 |
USA |
53 |
2 months–36 months |
General surgery, urology, otolaryngology, orthopaedics, plastic surgery, ophthalmology |
NR |
1.5%–2.5% |
200 μg kg−1 min−1
|
Objective Pain Scale |
Cohen and colleagues37
|
2004 |
USA |
56 |
<3 yr |
Infraumbilical and suprasternal procedures |
NR |
1.5%–2.5% |
200 μg kg−1 min−1
|
NR |
Auerswald and colleagues38
|
2006 |
Germany |
103 |
1–5 yr |
Adenoidectomy and adenotonsillectomy |
NR |
2%–3% |
5 mg kg−1 h−1
|
Smiley–Wert |
Chandler and colleagues39
|
2013 |
Canada |
94 |
2–6 yr |
Strabismus repair |
1 or 2 |
NR |
NR |
FLACC |
Hasani and colleagues3
|
2013 |
Kosova |
88 |
3–6 yr |
Hernia repair |
1 or 2 |
1.5%–2% |
9 mg kg−1 h−1
|
FPS |
Oriby and Elrashidy40
|
2021 |
Qatar |
84 |
3–11 yr |
Strabismus repair |
1 or 2 |
NR |
4 mg kg−1 h−1
|
FLACC |
Sheikhzade and colleagues41
|
2021 |
Iran |
80 |
2–10 yr |
Herniotomy, orchiopexy, frenulectomy, and sigmoidoscopy |
1 or 2 |
2%–3% |
100–250 μg kg−1 min−1
|
Wong–Baker Faces Pain Rating Scale |
Lopéz and colleagues42
|
1999 |
NR |
120 |
6 months to 12 yr |
Minor surgery below the umbilicus (e.g. inguinal hernia, circumcision, orchidopexy) |
NR |
1.7% |
5 mg kg−1 h−1
|
NR |
König and colleagues43
|
2009 |
USA |
179 |
2–12 yr |
Ambulatory dental surgery |
NR |
2% |
120–250 μg kg−1 min−1
|
FLACC, Oucher, and VAS |